Skip to NavigationSkip to content

News

An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan Police to levy...
AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional rights to two of the pharma...
A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower rates of age-...
The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of major adverse...
NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary thyroid cancer (MTC...
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey.
The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical trial sponsors to adequately...
GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the HIV Glasgow...
The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday.
New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not being used to their...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches